Amneal Pharmaceuticals, INC. (AMRX) — 10-Q Filings

All 10-Q filings from Amneal Pharmaceuticals, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Amneal Revenue Jumps 11.7% in Q3, Refinancing Costs Hit Profit — Nov 6, 2025 Risk: medium
Amneal Pharmaceuticals, Inc. (AMRX) reported a significant increase in net revenue for the three months ended September 30, 2025, reaching $784.5 million, up fr
Amneal Pharmaceuticals Files Q2 2025 10-Q — Aug 7, 2025 Risk: low
Amneal Pharmaceuticals, Inc. filed its quarterly report for the period ended June 30, 2025. The company is incorporated in Delaware and its Class A Common Stock
Amneal Pharmaceuticals Files Q1 2025 10-Q — May 7, 2025 Risk: low
Amneal Pharmaceuticals, Inc. filed its quarterly report for the period ending March 31, 2025. The filing details financial performance and operational updates f
Amneal Pharmaceuticals Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
Amneal Pharmaceuticals, Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the year,
Amneal Pharmaceuticals Files Q2 2024 10-Q — Aug 9, 2024 Risk: medium
Amneal Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second
Amneal Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — May 8, 2024 Risk: medium
Amneal Pharmaceuticals, Inc. (AMRX) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Amneal Pharmaceuticals, Inc. filed its quarterly report (10-Q)

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX